Skip to main content

Articles

Page 50 of 91

  1. Most studies on obesity surgery have measured renal function using the estimated GFR. However, due to the reduction of muscle mass, and therefore creatinine that accompanies weight loss, such measures can fals...

    Authors: Ling L. Chuah, Alexander D. Miras, Laura M. Perry, Andrew H. Frankel, David J. Towey, Zahraa Al-Mayahi, William Svensson and Carel W. le Roux
    Citation: BMC Nephrology 2018 19:383
  2. Congenital nephrotic syndrome (CNS) is characterised by increased proteinuria, hypoproteinemia, and edema beginning in the first 3 months of life. Recently, molecular genetic studies have identified several ge...

    Authors: Guo-min Li, Qi Cao, Qian Shen, Li Sun, Yi-hui Zhai, Hai-mei Liu, Yu An and Hong Xu
    Citation: BMC Nephrology 2018 19:382
  3. The worldwide prevalence of obesity is increasing. Obesity is associated with a variety of chronic diseases, including chronic kidney disease. Several studies suggested that body mass index (BMI) could be an i...

    Authors: Changwei Wu, Amanda Y. Wang, Guisen Li and Li Wang
    Citation: BMC Nephrology 2018 19:381
  4. Estimated glomerular filtration rate (eGFR) is the clinical standard for assessing kidney function and staging chronic kidney disease. Automated reporting of eGFR using the Modification of Diet in Renal Diseas...

    Authors: Kristine E. Lynch, Ji won Chang, Michael E. Matheny, Alexander Goldfarb, Olga Efimova, Gregorio Coronado and Scott L. DuVall
    Citation: BMC Nephrology 2018 19:380
  5. The prevalence of cognitive disorders in hemodialysis patients is twice as high as the general population, while these disorders often are undiagnosed. Timely prevention and treatment can improve their persona...

    Authors: Afshin Samaei, Monir Nobahar, Zaynab Hydarinia-Naieni, Abbas Ali Ebrahimian, Mohammad Reza Tammadon, Raheb Ghorbani and Abbas Ali Vafaei
    Citation: BMC Nephrology 2018 19:379
  6. Caffeine has been proposed, based on in vitro cultured cell studies, to accelerate progression of autosomal dominant polycystic kidney disease (ADPKD) by increasing kidney size. Since ADPKD patients are advise...

    Authors: Katelyn A. McKenzie, Mirelle El Ters, Vicente E. Torres, Peter C. Harris, Arlene B. Chapman, Michal Mrug, Frederic F. Rahbari-Oskoui, Kyongtae Ty Bae, Douglas P. Landsittel, William M. Bennett, Alan S. L. Yu and Jonathan D. Mahnken
    Citation: BMC Nephrology 2018 19:378
  7. The clinical outcome and health-related quality of life (HRQoL) of living kidney donors is mostly not detrimental, but some donors experience impairment after donation. Gender-specific effects of living kidney...

    Authors: Claudia Sommerer, Sarah Estelmann, Nicole G. Metzendorf, Maren Leuschner and Martin Zeier
    Citation: BMC Nephrology 2018 19:377
  8. To assess the time to first on-study vascular thromboembolic events (VTEs) of clopidogrel (CL) or beraprost sodium (BPS) in Chinese population with end-stage renal disease (ESRD) treated with arteriovenous fis...

    Authors: Yu Zhou, Ling Du, Bo Tu, Qiquan Lai, Xiaonan Du, Bo Xu, Fan Zhang, Mingdong Zhao, Ziming Wan and Jiajie Lai
    Citation: BMC Nephrology 2018 19:376
  9. Following publication of the original article [1], the authors reported an error in the presentation of Table 3 and Table 4.

    Authors: Jutta Dierkes, Helene Dahl, Natasha Lervaag Welland, Kristina Sandnes, Kristin Sæle, Ingegjerd Sekse and Hans-Peter Marti
    Citation: BMC Nephrology 2018 19:375

    The original article was published in BMC Nephrology 2018 19:259

  10. Recent studies have shown associations between contrast-induced acute kidney injury (CI-AKI) and increased risk of adverse clinical outcomes in acute coronary syndrome (ACS) patients undergoing percutaneous co...

    Authors: Yi Yang, Kaisha C. George, Ran Luo, Yichun Cheng, Weifeng Shang, Shuwang Ge and Gang Xu
    Citation: BMC Nephrology 2018 19:374
  11. The impact of contrast-induced acute kidney injury (CI-AKI) on patients with chronic renal disease is well-known. Remote ischemic preconditioning (RIPC) is a non-invasive method that can reduce the risk of CI-...

    Authors: Ali Ghaemian, Jamshid Yazdani, Soheil Azizi, Ali A. Farsavian, Maryam Nabati, Alireza Malekrah, Mozhdeh Dabirian, Fatemeh Espahbodi, Bahareh Mirjani, Hossein Mohsenipouya and Javad Heshmatian
    Citation: BMC Nephrology 2018 19:373
  12. Lupus nephritis (LN) is one of the most common manifestations of systemic lupus erythematosus (SLE) and is often the most serious organ complication and the cause of premature death of such a patient. Most of ...

    Authors: Marceli Lukaszewski, Kinga Kosiorowska, Dorota Kaminska, Marta Obremska, Oktawia Mazanowska and Magdalena Krajewska
    Citation: BMC Nephrology 2018 19:372
  13. This is the first qualitative study to explore patient decision-making regarding end-stage kidney disease (ESKD) treatment in sub-Saharan Africa. The study addresses an important gap in the literature concerni...

    Authors: Edward Appiah Boateng, Linda East and Catrin Evans
    Citation: BMC Nephrology 2018 19:371
  14. Uremic encephalopathy (UE), a toxic metabolic encephalopathy, is an uncommon complication resulting from endogenous uremic toxins in patients with severe renal failure. UE syndrome can range from mild inattent...

    Authors: Wen-Yu Gong, Shan-Shan Li, Zong-Chao Yu, Hong-Wei Wu, Liang-Hong Yin, Li-Fan Mei and Fan-Na Liu
    Citation: BMC Nephrology 2018 19:370
  15. The introduction of a continuous renal replacement therapy (CRRT) device into the extracorporeal membrane oxygenation (ECMO) circuit is widely used. However, excessive pressure transmitted to the CRRT device i...

    Authors: Soo Jin Na, Hee Jung Choi, Chi Ryang Chung, Yang Hyun Cho, Hye Ryoun Jang, Gee Young Suh and Kyeongman Jeon
    Citation: BMC Nephrology 2018 19:369
  16. Somatostatin (SST) inhibits intracellular cyclic adenosine monophosphate (cAMP) production and thus may modify cyst formation in autosomal dominant polycystic kidney disease (ADPKD). We investigated whether en...

    Authors: A. Lianne Messchendorp, Edwin M. Spithoven, Niek F. Casteleijn, Wendy A. Dam, Jacob van den Born, Wouter F. Tonnis, Carlo A. J. M. Gaillard and Esther Meijer
    Citation: BMC Nephrology 2018 19:368
  17. Urinary mitochondrial DNA (mtDNA) fragment level has been proposed as a biomarker of chronic kidney disease (CKD). In this study, we determine the relation between urinary mtDNA level and rate of renal functio...

    Authors: Zhongping WEI, Bonnie Ching-Ha KWAN, Kai Ming CHOW, Phyllis Mei-Shan CHENG, Cathy Choi-Wan LUK, Ka-Bik LAI, Philip Kam-Tao LI and Cheuk Chun SZETO
    Citation: BMC Nephrology 2018 19:367
  18. Estimation of GFR (eGFR) using formulae based on serum creatinine concentrations are commonly used to assess kidney function. Physical exercise can increase creatinine turnover and lean mass; therefore, this m...

    Authors: Kassia S. Beetham, Erin J. Howden, Nicole M. Isbel and Jeff S. Coombes
    Citation: BMC Nephrology 2018 19:366
  19. Bordetella pertussis infection is a known trigger of atypical hemolytic uremic syndrome (HUS). For patients suspected of having atypical HUS, prompt plasma exchange/infusion (PE/PI) or eculizumab (ECZ) treatment ...

    Authors: Ken Saida, Masao Ogura, Yuji Kano, Shingo Ishimori, Takahisa Yoshikawa, Hiroko Nagata, Mai Sato, Koichi Kamei and Kenji Ishikura
    Citation: BMC Nephrology 2018 19:365
  20. Distal renal tubular acidosis (dRTA) is a heterogeneous disorder characterized by normal anion gap metabolic acidosis. Autosomal recessive dRTA is usually caused by mutations occurring in ATP6V1B1 and ATP6V0A4...

    Authors: Xiangzhong Zhao, Jingru Lu, Yanxia Gao, Xiaoling Wang, Yanhua Lang and Leping Shao
    Citation: BMC Nephrology 2018 19:364
  21. Although the renal toxicity of Deferasirox, an oral iron chelator, has been reported to be mild, there have been reports of acute interstitial nephritis or Fanconi syndrome due to this agent. Thin basement mem...

    Authors: Keiko Oda, Kan Katayama, Akiko Tanoue, Tomohiro Murata, Yumi Hirota, Shoko Mizoguchi, Yosuke Hirabayashi, Takayasu Ito, Eiji Ishikawa, Kaoru Dohi and Masaaki Ito
    Citation: BMC Nephrology 2018 19:363
  22. Therapeutic plasma exchange (TPE) is an important therapy for recurrent focal segmental glomerulosclerosis (rFSGS) post kidney transplant. suPAR has been causally implicated in rFSGS, and shown to be a unique ...

    Authors: Nada Alachkar, Jing Li, Dany Matar, Vikas Vujjini, Sami Alasfar, Melissa Tracy, Jochen Reiser and Changli Wei
    Citation: BMC Nephrology 2018 19:361
  23. Evidence regarding the effect of psychosocial factors on hospital readmission in the setting of hemodialysis is limited. We examined whether social worker-assessed factors were associated with 30-day readmissi...

    Authors: Olufunmilola Adisa, Bernard G. Jaar, Tahsin Masud, Abyalew Sahlie, Catherine Obadina, Joshua Ang, Janice P. Lea and Laura C. Plantinga
    Citation: BMC Nephrology 2018 19:360
  24. Decreased heat shock protein 27 (HSP27) participates in many processes that are involved in cardiovascular (CV) disease. The objective of the study was to evaluate if HSP27 level was predictive of mortality as...

    Authors: Andrzej Jaroszyński, Anna Jaroszyńska, Tomasz Zaborowski, Anna Drelich-Zbroja, Tomasz Zapolski and Wojciech Dąbrowski
    Citation: BMC Nephrology 2018 19:359
  25. IgA nephropathy (IgAN) is one of the most common forms of idiopathic glomerular diseases and might lead to end-stage kidney disease. Accurate and non-invasive biomarkers for early diagnosis are required for ea...

    Authors: Zhengguang Guo, Zhao Wang, Chen Lu, Shufen Yang, Haidan Sun, Reziw, Yu Guo, Wei Sun and Hua Yue
    Citation: BMC Nephrology 2018 19:358
  26. Immunosuppressive treatment will predispose an idiopathic membranous nephropathy (iMN) patient to opportunistic infections. Disease severity is one of the main concerns for making the treatment decision. Urina...

    Authors: Ziyong Tang, Yue Wang, Liyuan Tao, Yanhong Guo, Yimu Zheng and Danxia Zheng
    Citation: BMC Nephrology 2018 19:357

    The Correction to this article has been published in BMC Nephrology 2019 20:50

  27. The hepatic circulation is involved in adaptive systemic responses to circulatory stress. However, it is vulnerable to both chronic hypervolemia and cardiac dysfunction. The influence of hemodialysis (HD) and ...

    Authors: Claire J. Grant, Trevor P. Wade, Charles A. McKenzie, Guido Filler, Christopher W. McIntyre and Shih-Han S. Huang
    Citation: BMC Nephrology 2018 19:356
  28. Renal thrombotic microangiopathy (TMA) is occasionally seen in biopsies with pauci-immune necrotizing crescentic glomerulonephritis (PCGN). Recent study indicated that the complement activation is more promine...

    Authors: Jianling Tao, Jonathan Lieberman, Richard A. Lafayette and Neeraja Kambham
    Citation: BMC Nephrology 2018 19:355
  29. Serum anti-phospholipase A2 receptor (PLA2R) antibody was correlated with disease activity of membranous nephropathy(MN). The predictive value of antibody titer changes on immunosuppressive response remains un...

    Authors: Chao Li, Hang Li, Yu-bing Wen, Xue-mei Li and Xue-wang Li
    Citation: BMC Nephrology 2018 19:354
  30. The effect of chronic hepatitis B virus (HBV) infection on the risk of chronic kidney disease (CKD) is controversial. We examined the prospective association between hepatitis B surface antigen (HBsAg) serolog...

    Authors: Yun Soo Hong, Seungho Ryu, Yoosoo Chang, Miguel Caínzos-Achirica, Min-Jung Kwon, Di Zhao, Tariq Shafi, Mariana Lazo, Roberto Pastor-Barriuso, Hocheol Shin, Juhee Cho and Eliseo Guallar
    Citation: BMC Nephrology 2018 19:353
  31. Baclofen is a centrally acting GABAB receptor agonist and it is used widely for the treatment of spasticity, persistent hiccups and multiple sclerosis. The renal system is the main route of excretion, thus people...

    Authors: Emad Khazneh, Alaa Shamlawi, Kamel Jebrin, Zakaria Hamdan and Osama Sawalmeh
    Citation: BMC Nephrology 2018 19:352
  32. Contrast enhanced ultrasonography (CEUS) assessment of kidney allografts mainly focuses on graft rejection. However, studies on delayed graft function (DGF) without acute rejection are still lacking. The aim o...

    Authors: Nordeval Cavalcante Araújo and José Hermógenes Rocco Suassuna
    Citation: BMC Nephrology 2018 19:351
  33. Maternally inherited diabetes and deafness (MIDD), a mitochondrial genetic disorder, typically affects the kidneys and results in end-stage renal disease. Early diagnosis of MIDD is challenging when renal mani...

    Authors: Keiji Sugai, Hiroyuki Ueda, Keita Morimoto, Mai Tanaka, Daisuke Takahashi, Akio Nakashima, Junichiro Kato, Hiroshi Takahashi, Yutaka Yamaguchi, Tetsuya Kawamura, Kazushige Hanaoka, Yoichi Miyazaki and Takashi Yokoo
    Citation: BMC Nephrology 2018 19:350
  34. Nephrolithiasis is a global healthcare problem with a current lifetime risk of 18.8% in men and 9.4% in women. Given the high cost of medical treatments and surgical interventions as well as the morbidity rela...

    Authors: Nasser A. Dhayat, Nicolas Faller, Olivier Bonny, Nilufar Mohebbi, Alexander Ritter, Lisa Pellegrini, Giulia Bedino, Carlo Schönholzer, Reto M. Venzin, Carina Hüsler, Irene Koneth, Rosaria Del Giorno, Luca Gabutti, Patrizia Amico, Michael Mayr, Urs Odermatt…
    Citation: BMC Nephrology 2018 19:349
  35. Post-transplant diabetes mellitus (PTDM) is an emerging problem in kidney transplantation, representing an important risk factor for kidney function loss. Diabetic nephropathy (DN) occurrence in transplanted k...

    Authors: Marilena Gregorini, Vincenzo Sepe, Francesca Eleonora Pattonieri, Anna Allesina and Teresa Rampino
    Citation: BMC Nephrology 2018 19:348
  36. Albuminuria has been classically considered a marker of kidney damage progression in diabetic patients and it is routinely assessed to monitor kidney function. However, the role of a mild GFR reduction on the ...

    Authors: Antonio Mirijello, Francesca Viazzi, Paola Fioretto, Carlo Giorda, Antonio Ceriello, Giuspina T. Russo, Pietro Guida, Roberto Pontremoli and Salvatore De Cosmo
    Citation: BMC Nephrology 2018 19:347
  37. The end stage renal disease population has a 20 fold higher incidence of cardiovascular mortality compared to the overall population. The development of reno-cardiac syndrome in these patients will result in c...

    Authors: Julius E. Kieswich, Jianmin Chen, Samira Alliouachene, Paul W. Caton, Kieran McCafferty, Christoph Thiemermann and Muhammad M. Yaqoob
    Citation: BMC Nephrology 2018 19:346
  38. Chronic Kidney Disease (CKD), the worldwide Public Health problem, is also one of the rising non-communicable diseases in low and middle-income countries. Its early detection and treatment using readily availa...

    Authors: Tamiru Adugna, Hailu Merga and Esayas Kebede Gudina
    Citation: BMC Nephrology 2018 19:345
  39. Acute kidney injury (AKI) is an underestimated, yet important, risk factor for the development of chronic kidney disease (CKD). Persistence of inflammation after a renal ischemic injury has been observed, both...

    Authors: Lies Moonen, Hilde Geryl, Patrick C. D’Haese and Benjamin A. Vervaet
    Citation: BMC Nephrology 2018 19:343
  40. Like most of the sub-Saharan countries, Tanzania faces significant increase in the number of patients diagnosed with an end-stage renal disease (ESRD) among which only a few manage to receive chronic haemodial...

    Authors: Godwin Pancras, Judith Shayo and Amani Anaeli
    Citation: BMC Nephrology 2018 19:342
  41. Peritoneal dialysis (PD)-associated infection caused by Mycobacterium spp. is rare. Mycobacterium abscessus is one of the most resistant acid-fast bacteria, and treatment is also the most difficult and refractory...

    Authors: Ryuichi Yoshimura, Miharu Kawanishi, Shungo Fujii, Aska Yamauchi, Kentaro Takase, Kaori Yoshikane, Masahiro Egawa, Hiroaki Shiina and Takafumi Ito
    Citation: BMC Nephrology 2018 19:341
  42. Patient experience in hemodialysis (HD) is measured twice yearly in all in-center HD patients in the United States using the In-Center Hemodialysis Consumer Assessment of Healthcare Providers and Systems (ICH ...

    Authors: Taimur Dad, Hocine Tighiouart, Eduardo Lacson Jr, Klemens B. Meyer, Daniel E. Weiner and Michelle M. Richardson
    Citation: BMC Nephrology 2018 19:340
  43. To date, limited research has been dedicated to exploring the experience of decision-making for chronic kidney disease (CKD) patients who have initiated dialysis and have to make decisions in the context of ma...

    Authors: Danielle Marie Muscat, Roshana Kanagaratnam, Heather L. Shepherd, Kamal Sud, Kirsten McCaffery and Angela Webster
    Citation: BMC Nephrology 2018 19:339
  44. Immunoglobulin heavy-and-light-chain amyloidosis (AHL amyloidosis) is a newly established disease entity where both the immunoglobulin heavy-chain and light-chain compose amyloid fibrils. The immunoglobulins r...

    Authors: Shun Manabe, Chihiro Iwasaki, Michiyasu Hatano, Fuyuki Kametani, Masahide Yazaki, Kosaku Nitta and Michio Nagata
    Citation: BMC Nephrology 2018 19:337
  45. There is a need for a large, contemporary, multi-centre series of measured glomerular filtration rates (mGFR) from healthy individuals to determine age- and gender-specific reference ranges for GFR. We aimed t...

    Authors: Anthony Fenton, Emma Montgomery, Peter Nightingale, A. Michael Peters, Neil Sheerin, A. Caroline Wroe and Graham W. Lipkin
    Citation: BMC Nephrology 2018 19:336
  46. Focal segmental glomerulosclerosis (FSGS) is the most common glomerular etiology of end-stage kidney disease (ESKD). Increasing evidence has indicated the reparative potential of mesenchymal stem cells (MSCs) ...

    Authors: Ru-chun Yang, Xiao-ling Zhu, Jun Wang, Feng Wan, Hua-qin Zhang, Yi Lin, Xuan-li Tang and Bin Zhu
    Citation: BMC Nephrology 2018 19:335
  47. IgA vasculitis (IgAV, formerly Henoch-Schönlein purpura) is a type of systemic vasculitis. This study aimed to explore the clinicopathological features, treatment and renal outcomes of adult IgAV-related nephr...

    Authors: Xiao Huang, Jing Wu, Xiao-mei Wu, Ya-xin Hao, Cai-hong Zeng, Zhi-hong Liu and Zheng Tang
    Citation: BMC Nephrology 2018 19:334

Affiliated with

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 2.2
    5-year Journal Impact Factor: 2.6
    Source Normalized Impact per Paper (SNIP): 0.907
    SCImago Journal Rank (SJR): 0.697

    Speed 2023
    Submission to first editorial decision (median days): 22
    Submission to acceptance (median days): 158

    Usage 2023
    Downloads: 3,053,628
    Altmetric mentions: 3,742

Peer-review Terminology

  • The following summary describes the peer review process for this journal:

    Identity transparency: Single anonymized

    Reviewer interacts with: Editor

    Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication

    More information is available here

Sign up for article alerts and news from this journal